Engineered chip mimics bone marrow and immune system, offering a faster, tailored path for cancer immunotherapy.

Estrogen receptor positive breast cancer is the most common form of the disease, and cancer cells of this kind can live for years -- or even decades -- in bone marrow after remission.

Bone marrow transplants, long a mainstay of blood cancer treatment, are becoming less common as more turn to alternatives like CAR-T therapy. Skip to Main Content. Manage alerts for this article; ...